Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

Similar articles for PubMed (Select 12910262)


Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts.

Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ.

Nat Med. 2003 Sep;9(9):1195-201. Epub 2003 Aug 10.


AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.

Yu YS, Shen ZY, Ye WX, Huang HY, Hua F, Chen YH, Chen K, Lao WJ, Tao L.

Chin Med J (Engl). 2010 Jul;123(13):1702-8.


Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.

Noiseux N, Gnecchi M, Lopez-Ilasaca M, Zhang L, Solomon SD, Deb A, Dzau VJ, Pratt RE.

Mol Ther. 2006 Dec;14(6):840-50. Epub 2006 Sep 11.


Akt helps stem cells heal the heart.

KoƧ ON, Gerson SL.

Nat Med. 2003 Sep;9(9):1109-10. No abstract available.


Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium.

Song SW, Chang W, Song BW, Song H, Lim S, Kim HJ, Cha MJ, Choi E, Im SH, Chang BC, Chung N, Jang Y, Hwang KC.

Stem Cells. 2009 Jun;27(6):1358-65. doi: 10.1002/stem.47.


The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.

Lim SY, Kim YS, Ahn Y, Jeong MH, Hong MH, Joo SY, Nam KI, Cho JG, Kang PM, Park JC.

Cardiovasc Res. 2006 Jun 1;70(3):530-42. Epub 2006 Mar 6.


Stem cells in cardiac repair.

Henning RJ.

Future Cardiol. 2011 Jan;7(1):99-117. doi: 10.2217/fca.10.109. Review.


SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.

Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, Koc ON, Penn MS.

FASEB J. 2007 Oct;21(12):3197-207. Epub 2007 May 11.


Autologous stem cell transplantation for myocardial repair.

Liu J, Hu Q, Wang Z, Xu C, Wang X, Gong G, Mansoor A, Lee J, Hou M, Zeng L, Zhang JR, Jerosch-Herold M, Guo T, Bache RJ, Zhang J.

Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H501-11.


Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction.

Grauss RW, Winter EM, van Tuyn J, Pijnappels DA, Steijn RV, Hogers B, van der Geest RJ, de Vries AA, Steendijk P, van der Laarse A, Gittenberger-de Groot AC, Schalij MJ, Atsma DE.

Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2438-47. Epub 2007 Jul 20.


Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair.

Jiang S, Haider HKh, Idris NM, Salim A, Ashraf M.

Circ Res. 2006 Sep 29;99(7):776-84. Epub 2006 Sep 7. Erratum in: Circ Res. 2006 Oct 27;99(9):e85.


Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ.

Nat Med. 2005 Apr;11(4):367-8. No abstract available.


Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells.

Song H, Chang W, Lim S, Seo HS, Shim CY, Park S, Yoo KJ, Kim BS, Min BH, Lee H, Jang Y, Chung N, Hwang KC.

Stem Cells. 2007 Jun;25(6):1431-8. Epub 2007 Mar 8.


Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis.

Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K, Kitamura S.

Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2670-6. Epub 2004 Jul 29.


Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement.

Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ.

FASEB J. 2006 Apr;20(6):661-9.


Regeneration of the infarcted heart with stem cells derived by nuclear transplantation.

Lanza R, Moore MA, Wakayama T, Perry AC, Shieh JH, Hendrikx J, Leri A, Chimenti S, Monsen A, Nurzynska D, West MD, Kajstura J, Anversa P.

Circ Res. 2004 Apr 2;94(6):820-7. Epub 2004 Feb 5.


Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: role of beta-catenin transduction and cell dose.

Templin C, Kotlarz D, Faulhaber J, Schnabel S, Grote K, Salguero G, Luchtefeld M, Hiller KH, Jakob P, Naim HY, Schieffer B, Hilfiker-Kleiner D, Landmesser U, Limbourg FP, Drexler H.

J Mol Cell Cardiol. 2008 Sep;45(3):394-403. doi: 10.1016/j.yjmcc.2008.06.010. Epub 2008 Jul 11.


Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway.

Tang J, Wang J, Kong X, Yang J, Guo L, Zheng F, Zhang L, Huang Y, Wan Y.

Exp Cell Res. 2009 Dec 10;315(20):3521-31. doi: 10.1016/j.yexcr.2009.09.026. Epub 2009 Oct 2.


Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling.

Singla DK, Lyons GE, Kamp TJ.

Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1308-14. Epub 2007 Apr 6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk